Early severe vasomotor menopausal symptoms are associated with diabetes

被引:2
|
作者
Herber-Gast, Gerrie-Cor M. [1 ]
Mishra, Gita D. [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
Diabetes; Epidemiology; Hot flushes; Menopause; Night sweats; WOMENS HEALTH; POSTMENOPAUSAL WOMEN; HOT FLASHES; INSULIN-RESISTANCE; RISK-FACTORS; NATION; MIDLIFE; COHORT; TRANSITION; MELLITUS;
D O I
10.1097/gme.0000000000000171
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to investigate associations between profiles of vasomotor menopausal symptoms (VMS) during the menopausal transition with the prevalence of diabetes. Methods: VMS and diabetes were measured at baseline and 3-year intervals for 15 years in 4,895 women in the Australian Longitudinal Study on Women's Health who were aged 45 to 50 years at baseline in 1996. Latent class analysis and generalized estimating equation models for binary repeated measures were performed. The VMS profiles were labeled as mild, moderate, early severe, and late severe. Results: The prevalence of diabetes in the total group was 9.0%. Compared with mild VMS, the odds of diabetes were higher in those with a late severe profile (though not statistically significant; adjusted odds ratio, 1.28; 95% CI, 0.97-1.68) and in those with an early severe profile (adjusted odds ratio, 1.67; 95% CI, 1.20-2.32). Adjustment for body mass index attenuated this association, but the odds of diabetes were still significantly higher in women with an early severe profile than in women with mild VMS (odds ratio, 1.55; 95% CI, 1.11-2.17). The moderate profile was not associated with diabetes. Conclusions: Women with an early severe VMS profile are more likely to have diabetes across a period of 15 years. This association is not explained by body mass index or other potential confounders. Our findings imply that the predictive value of VMS for diabetes may vary with the timing of VMS relative to menopause.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 50 条
  • [41] Menopausal vasomotor symptoms and subclinical atherosclerotic cardiovascular disease
    Nilsson, S.
    Qvick, A.
    Henriksson, M.
    Lawesson, S. Sederholm
    Holm, A. C. Spetz
    Leander, K.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [42] Menopausal vasomotor symptoms and adiponectin among midlife women
    Thurston, Rebecca C.
    Chang, Yuefang
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (10): : 1145 - 1149
  • [43] Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
    Avis, Nancy E.
    Crawford, Sybil L.
    Greendale, Gail
    Bromberger, Joyce T.
    Everson-Rose, Susan A.
    Gold, Ellen B.
    Hess, Rachel
    Joffe, Hadine
    Kravitz, Howard M.
    Tepper, Ping G.
    Thurston, Rebecca C.
    JAMA INTERNAL MEDICINE, 2015, 175 (04) : 531 - 539
  • [44] Phytoestrogens for menopausal vasomotor symptoms: A Cochrane review summary
    Roberts, Helen
    Lethaby, Anne
    MATURITAS, 2014, 78 (02) : 79 - 81
  • [45] Menopausal vasomotor symptoms (MVS) survey for assessment of hot flashes
    Ratka, A
    Miller, V
    Brown, K
    Raut, A
    Cipher, D
    Meczekalski, B
    Simpkins, JW
    JOURNAL OF WOMENS HEALTH, 2006, 15 (01) : 77 - 89
  • [46] Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer
    Vogel, Marie
    Franik, Sebastian
    Kiesel, Ludwig
    BREAST CARE, 2023, 18 (03) : 158 - 162
  • [47] Physical Activity History And Severity Of Vasomotor Symptoms In Menopausal Females
    Kowal, Rachel
    Chomentowski, Peter
    Hill, Chris
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 74 - 74
  • [48] Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women
    Thurston, Rebecca C.
    Wu, Minjie
    Chang, Yue-Fang
    Aizenstein, Howard J.
    Derby, Carol A.
    Barinas-Mitchell, Emma A.
    Maki, Pauline
    NEUROLOGY, 2023, 100 (02) : E133 - E141
  • [49] Efficacy and safety of desvenlafaxine succinate for treatment of menopausal vasomotor symptoms
    Gass, Margery
    Olivier, Sophie
    Constantine, Ginger
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 75S - 75S
  • [50] Soy Isoflavones for Prevention of Menopausal Bone Loss and Vasomotor Symptoms
    Newton, Katherine M.
    Grady, Deborah
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (15) : 1369 - 1370